← Eichor
Study identifier: NCT06068530 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mass Vaccine and Drug Administration, Bangladesh

Condition: Plasmodium Falciparum Malaria  ·  Sponsor: University of Oxford

PhasePhase 4
Planned participants10000
Who can joinAll sexes, 6 Months to no upper limit
Healthy volunteersNo

About this study

This is an open i.e. not blinded, cluster-randomised, controlled intervention study. The study will use a factorial design to estimate the protective effectiveness of mass drug administrations, mass vaccinations, combined mass vaccinations and drug administrations versus the current standard of care.

This description comes directly from the study's public registry record.

Talk to the study team

Lorenz von Seidlein  ·  +66926486322  ·  Lorenz@tropmedres.ac

Rupam Tripura  ·  +8801572288558  ·  Rupam@tropmedres.ac

Always discuss trial participation with your own doctor first.

Locations (2)

Alikadam Upazila Health ComplexBāndarban, BangladeshRecruiting
Lama Upazila Health ComplexLāma, BangladeshRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06068530